col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: International Research and Cooperation Association for Bio & Socio-Sciences Advancement

87 Results       Page 1

  original article Journal Date Title Authors All Authors
1 [GO] BioScience Trends 2022―Sep―11 An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19 pandemic on the healthcare system in Japan? Kenji Karako, Peipei Song, Yu Chen, Takashi Karako
2 [GO] Drug Discoveries & Therapeutics 2022―Sep―05 Relaxation of all-case reporting of COVID-19 cases in Japan Kenji Karako
3 [GO] Drug Discoveries & Therapeutics 2022―Aug―20 Prevalence of SARS-CoV-2 antibodies among university athletic club members: A cross-sectional survey Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, et al. (+4)
4 [GO] BioScience Trends 2022―Jul―29 Heparin therapy in COVID-19: Call for randomized controlled trials (RCTs) Tingting Fang, Xianyang Pan, Ju Huang, Jun Chen, Shuli Song, Qilin Zhan
5 [GO] BioScience Trends 2022―Jul―16 The role of influenza in the era of COVID-19: Can we forget it? Ting Li, Tetsuya Asakawa, Hui Liu, Cordia Chu, Hongzhou Lu
6 [GO] Drug Discoveries & Therapeutics 2022―Jun―25 Evaluation of Japanese university students' perception of smoking, interest in quitting, and smoking behavior: An examination and public health challenges during the COVID-19 pandemic Makoto Aoike, Yukihiro Mori, Kiyoshi Hotta, Yukihiro Shigeno, Yuka Aoyama, Mamoru Tanaka, et al. (+4)
7 [GO] Drug Discoveries & Therapeutics 2022―Jun―24 Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron era Takehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, Keita Sakamoto, Kohei Takada, Yutaka Muto, et al. (+5)
8 [GO] BioScience Trends 2022―Jun―21 How should designated COVID-19 hospitals in megacities implement a precise management strategy in response to Omicron? Jing Cao, Min Wen, Yirong Shi, Ting Huang, Yunlan Yi, Youfeng Su, et al. (+3)
9 [GO] BioScience Trends 2022―Jun―21 Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule Jing Zhang, Lili Liu, Guoliang Zhang, Mingqiang Li, Bitao Ma, Wenming Yang
10 [GO] BioScience Trends 2022―Jun―16 Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, China Minxing Chen, Ruijia Li, Gang Ding, Chunlin Jin
11 [GO] Drug Discoveries & Therapeutics 2022―May―05 Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? Guangbin Chen, Hongzhou Lu
12 [GO] Drug Discoveries & Therapeutics 2022―Apr―03 Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, et al. (+4)
13 [GO] BioScience Trends 2022―Mar―16 An innovative two-wing model for balancing the demands of inpatients with COVID-19 and general medical service in a designated hospital for COVID-19 in Shenzhen, China Xiaoning Liu, Jing Cao, Yiling Ji, Ting Li, Zheng Zhu, Ting Huang, Hongzhou Lu
14 [GO] Drug Discoveries & Therapeutics 2022―Mar―08 Effect of corticosteroids in patients with COVID-19 early stage pneumonia and risk of disease progression: An uncharted territory Anabel Franco-Moreno, María Soledad Acedo-Gutiérrez, Rodolfo Romero-Pareja, Juan Torres-Macho
15 [GO] Drug Discoveries & Therapeutics 2022―Mar―08 Waning COVID-19 vaccine effectiveness in Japan Junko Kurita, Tamie Sugawara, Yasushi Ohkusa
16 [GO] Drug Discoveries & Therapeutics 2022―Mar―08 The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials Basel Abdelazeem, Ahmed K. Awad, Merihan A. Elbadawy, Nouraldeen Manasrah, Bilal Malik, Amman Yousaf, et al. (+3)
17 [GO] Drug Discoveries & Therapeutics 2022―Jan―14 Drug discovery to treat COVID-19 two years after its outbreak Jianjun Gao, Fusheng Sun
18 [GO] Drug Discoveries & Therapeutics 2022―Jan―14 Pneumothorax and pneumomediastinum in patients with COVID-19: A retrospective study from tertiary care institute in India Saurav Sekhar Paul, Bhavesh Mohan Lal, Animesh Ray, Ved Prakash Meena, Rohit Kumar Garg, Pawan Tiwari, et al. (+6)
19 [GO] Drug Discoveries & Therapeutics 2021―Dec―29 Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review Yayun Xu, Li Yang, Longfei Wang, Feihu Chen
20 [GO] BioScience Trends 2021―Dec―27 The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022 Peipei Song, Takashi Karako
21 [GO] BioScience Trends 2021―Dec―17 From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases Mingyu Luo, Qinmei Liu, Jinna Wang, Zhenyu Gong
22 [GO] Drug Discoveries & Therapeutics 2021―Oct―29 Post COVID-19 sequelae: A prospective observational study from Northern India Shivdas Naik, Soumendra Nath Haldar, Manish Soneja, Netto George Mundadan, Prerna Garg, Ankit Mittal, et al. (+22)
23 [GO] Drug Discoveries & Therapeutics 2021―Oct―27 Role of systemic corticosteroids in preventing hypoxia among patients with mild COVID-19: An observational study Anivita Aggarwal, Ankit Mittal, Manish Soneja, Sujay Halkur Shankar, Shivdas Naik, Parul Kodan, et al. (+4)
24 [GO] Drug Discoveries & Therapeutics 2021―Oct―27 Antiviral effect of electrolyzed reduced water on SARS-CoV-2 Yoshinao Okajima, Masahiro Okajima, Mitsuo Ikeda, Yuko Wada, Ken-ichi Shimokawa, Fumiyoshi Ishii
25 [GO] Drug Discoveries & Therapeutics 2021―Oct―25 Does immunosuppressive property of non-steroidal anti-inflammatory drugs (NSAIDs) reduce COVID-19 vaccine-induced systemic side effects? Itsuro Kazama, Momono Senzaki
26 [GO] BioScience Trends 2021―Aug―29 Considerations and guidance to control the rebound in COVID-19 cases Qian Li, Xiangming Zhan, Jun Wang, Hongzhou Lu
27 [GO] Drug Discoveries & Therapeutics 2021―Aug―25 India and management of COVID-19: A case study on published guidelines Rohit Kumar, Ankit Mittal, Shreya Das Adhikari, Eram Afroz, Nitin Gupta
28 [GO] BioScience Trends 2021―Aug―24 Update: Drug treatment options for coronavirus disease 2019 (COVID-19) Yueming Shao, Jun Chen, Hongzhou Lu
29 [GO] Drug Discoveries & Therapeutics 2021―Jul―18 Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021 Cui Xiaoni, Wang Pengxiang, Wei Zhun
30 [GO] BioScience Trends 2021―Jul―14 The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, Atsushi Iwata, Tatsushi Toda, Takeshi Iwatsubo
31 [GO] BioScience Trends 2021―Jul―12 Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures Tatsuo Sawakami, Kenji Karako, Peipei Song, Wataru Sugiura, Norihiro Kokudo
32 [GO] Drug Discoveries & Therapeutics 2021―Jul―05 Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19 Qian Li, Jun Wang, Yang Tang, Hongzhou Lu
33 [GO] Drug Discoveries & Therapeutics 2021―Jul―05 Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India Neha Chopra, Mohit Chowdhury, Anupam K Singh, Khan MA, Arvind Kumar, Piyush Ranjan, et al. (+2)
34 [GO] Drug Discoveries & Therapeutics 2021―Jul―05 Antimicrobial resistance and COVID-19 syndemic: Impact on public health Ashima Jain Vidyarthi, Arghya Das, Rama Chaudhry
35 [GO] BioScience Trends 2021―Jun―30 Rapid evolution of the COVID-19 pandemic calls for a unified public health response Na He
36 [GO] BioScience Trends 2021―Jun―25 Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza Qian Li, Jun Wang, Haiwei Lv, Hongzhou Lu
37 [GO] BioScience Trends 2021―Jun―15 Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19 Jie Su, Hongzhou Lu
38 [GO] BioScience Trends 2021―Jun―15 What is always necessary throughout efforts to prevent and control COVID-19 and other infectious diseases? A physical containment strategy and public mobilization and management Mingyu Luo, Jimin Sun, Zhenyu Gong, Zhen Wang
39 [GO] BioScience Trends 2021―Mar―25 Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease Ying Lv, Yuanyuan Ma, Yanhui Si, Xiaoyi Zhu, Lin Zhang, Haiyan Feng, et al. (+5)
40 [GO] BioScience Trends 2021―Mar―25 Burnout in nurses during the COVID-19 pandemic in China: New challenges for public health Lin Zhang, Ling Chai, Yihong Zhao, Lin Wang, Wenxiu Sun, Lingqing Lu, et al. (+2)
41 [GO] BioScience Trends 2021―Mar―18 COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer Yamin Chen, Luying Cheng, Rongna Lian, Ziwei Song, Jinhui Tian
42 [GO] BioScience Trends 2021―Mar―18 New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals Jun Chen, Hongzhou Lu
43 [GO] Drug Discoveries & Therapeutics 2021―Feb―27 Clinical profile and outcomes of asymptomatic vs. symptomatic travellers diagnosed with COVID-19: An observational study from a coastal town in South India Nitin Gupta, Anupa John, Mohammed Safeer Kokkottil, Muralidhar Varma, Shashikiran Umakanth, Kavitha Saravu
44 [GO] BioScience Trends 2021―Feb―22 Transitional care during COVID-19 pandemic in Japan: Calls for new strategies to integrate traditional approaches with information and communication technologies Yuka Sumikawa, Noriko Yamamoto-Mitani
45 [GO] Drug Discoveries & Therapeutics 2021―Feb―18 Multidrug treatment for COVID-19 Masashi Ohe, Ken Furuya, Houman Goudarzi
46 [GO] BioScience Trends 2021―Jan―28 Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021 Kenji Karako, Peipei Song, Yu Chen, Wei Tang, Norihiro Kokudo
47 [GO] Drug Discoveries & Therapeutics 2020―Dec―30 Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2 Ines ElBini Dhouib
48 [GO] Drug Discoveries & Therapeutics 2020―Dec―29 COVID-19 in patients living with human immunodeficiency virus (HIV) infection: Challenges and way-forward Manasvini Bhatt, Manish Soneja, Nitin Gupta
49 [GO] Drug Discoveries & Therapeutics 2020―Dec―29 Approach to acute febrile illness during the COVID-19 pandemic Manasvini Bhatt, Manish Soneja, Nitin Gupta
50 [GO] Drug Discoveries & Therapeutics 2020―Dec―29 Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic Yaser Pashaei
51 [GO] BioScience Trends 2020―Dec―26 Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19? Masashi Ohe, Ken Furuya, Houman Goudarzi
52 [GO] BioScience Trends 2020―Dec―24 Latest updates on COVID-19 vaccines Qian Li, Hongzhou Lu
53 [GO] BioScience Trends 2020―Dec―17 Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China Yi Su, Yun Ling, Yuyan Ma, Lili Tao, Qing Miao, Qingfeng Shi, et al. (+3)
54 [GO] Drug Discoveries & Therapeutics 2020―Oct―28 Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis? Mir S. Adil, S. Priya Narayanan, Payaningal R. Somanath
55 [GO] BioScience Trends 2020―Oct―24 An overview of potential therapeutic agents to treat COVID-19 Xueqin Dong, Zhenxue Tian, Chengwu Shen, Cuirong Zhao
56 [GO] BioScience Trends 2020―Oct―24 The development of a quarantine strategy is an important path to a normalized response to COVID-19 Han Zhu, Hongzhou Lu
57 [GO] Drug Discoveries & Therapeutics 2020―Sep―07 Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19 Shweta Sinha, Alka Sehgal, Rakesh Sehgal
58 [GO] Drug Discoveries & Therapeutics 2020―Sep―07 Laboratory diagnosis of COVID-19 in Africa: availability, challenges and implications Elijah Kolawole Oladipo, Ayodeji Folorunsho Ajayi, Aduragbemi Noah Odeyemi, Olawumi Elizabeth Akindiya, Emmanuel Tayo Adebayo, Ayomide Samuel Oguntomi, et al. (+6)
59 [GO] Drug Discoveries & Therapeutics 2020―Sep―07 Review of current clinical management guidelines for COVID-19 with special reference to India Rohit Kumar, Kutty Sharada Vinod, Ankit Mittal, Shreya Das Adhikari, Nitin Gupta
60 [GO] Intractable & Rare Diseases Research 2020―Sep―03 A case of coronavirus disease 2019 in acquired immunodeficiency syndrome patient: a case report and review of the literature Abdallah Qasim, Mohamed Mansour, Omar Kousa, Dana Awad, Bader Abuhazeem, Paul Millner, Manasa Velagapudi
61 [GO] Drug Discoveries & Therapeutics 2020―Jul―14 Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies Bushra Hassan Marouf, Kawa Dizaye
62 [GO] Drug Discoveries & Therapeutics 2020―Jul―14 Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research Jinjing Wang, Fanghua Qi
63 [GO] Drug Discoveries & Therapeutics 2020―Jun―24 Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy? Itsuro Kazama
64 [GO] BioScience Trends 2020―Jun―20 Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China Mingshan Xue, Peiyan Zheng, Xiqing Bian, Zhifeng Huang, Huimin Huang, Yifeng Zeng, et al. (+6)
65 [GO] Drug Discoveries & Therapeutics 2020―Jun―15 Can mesenchymal stem cell therapy be the interim management of COVID-19? Chitra Bamba, Surinder P. Singh, Sangeeta Choudhury
66 [GO] BioScience Trends 2020―Jun―11 Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19 Xianmin Meng, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, Hongzhou Lu
67 [GO] BioScience Trends 2020―May―27 Predicting intervention effect for COVID-19 in Japan: state space modeling approach Genya Kobayashi, Shonosuke Sugasawa, Hiromasa Tamae, Takayuki Ozu
68 [GO] BioScience Trends 2020―May―15 Does immune privilege result in recovered patients testing positive for COVID-19 again? Jufeng Xia
69 [GO] BioScience Trends 2020―May―08 Introduction on collective quarantine of close contacts of patients with COVID-19 for medical observation in China: from the perspective of frontline staff Chenjie Dong, Yuan Tian, Wenzhong Xu, Jiangjiang He, Duo Chen, Jie Zhu, Ping Lu
70 [GO] Drug Discoveries & Therapeutics 2020―May―05 Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far? Yuanyuan Zhang, Yanyan Zhong, Lin Pan, Jing Dong
71 [GO] BioScience Trends 2020―Apr―29 Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China Ying Zou, Hongying Guo, Yuyi Zhang, Zhengguo Zhang, Yu Liu, Jiefei Wang, et al. (+2)
72 [GO] BioScience Trends 2020―Apr―26 Suggestions on surgical treatment during coronavirus disease 2019 (COVID-19) pandemic Zhiming Zhao, Mengyang Li, Rong Liu
73 [GO] Drug Discoveries & Therapeutics 2020―Apr―24 Treatment of SARS-CoV-2: How far have we reached? Waquar Ahsan, Shamama Javed, Mohammed Al Bratty, Hassan A. Alhazmi, Asim Najmi
74 [GO] BioScience Trends 2020―Apr―21 Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up Jiao Zhang, Shoucai Wu, Lingzhong Xu
75 [GO] BioScience Trends 2020―Apr―21 A practice of anesthesia scenario design for emergency cesarean section in patients with COVID-19 infection based on the role of standard patient Yin Kang, Longjiao Deng, Dengwen Zhang, Yuehong Wang, Gang Wang, Li Mei, et al. (+2)
76 [GO] Drug Discoveries & Therapeutics 2020―Apr―20 Is GSK3β a molecular target of chloroquine treatment against COVID-19? Mohammed Noor Embi, Nagesswary Ganesan, Hasidah Mohd Sidek
77 [GO] BioScience Trends 2020―Apr―12 Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) Jianjun Gao, Shasha Hu
78 [GO] BioScience Trends 2020―Apr―04 Macrolide treatment for COVID-19: Will this be the way forward? Masashi Ohe, Haruki Shida, Satoshi Jodo, Yoshihiro Kusunoki, Masahide Seki, Ken Furuya, Houman Goudarzi
79 [GO] BioScience Trends 2020―Mar―31 Mobile field hospitals, an effective way of dealing with COVID-19 in China: sharing our experience Zhi Chen, Shan He, Fan Li, Junxiang Yin, Xiaoliang Chen
80 [GO] Drug Discoveries & Therapeutics 2020―Mar―25 Facts and reflections on COVID-19 and anti-hypertensives drugs Gustavo H. Marin
81 [GO] BioScience Trends 2020―Mar―18 Analysis of COVID-19 infection spread in Japan based on stochastic transition model Kenji Karako, Peipei Song, Yu Chen, Wei Tang
82 [GO] Drug Discoveries & Therapeutics 2020―Mar―07 Discovering drugs to treat coronavirus disease 2019 (COVID-19) Liying Dong, Shasha Hu, Jianjun Gao
83 [GO] BioScience Trends 2020―Feb―24 COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern Peipei Song, Takashi Karako
84 [GO] BioScience Trends 2020―Feb―18 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Jianjun Gao, Zhenxue Tian, Xu Yang
85 [GO] BioScience Trends 2020―Feb―16 Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China Xu Wang, Xiaoxi Zhang, Jiangjiang He
86 [GO] BioScience Trends 2020―Feb―08 Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment Zhenwei Wang, Xiaorong Chen, Yunfei Lu, Feifei Chen, Wei Zhang
87 [GO] BioScience Trends 2020―Jan―27 Drug treatment options for the 2019-new coronavirus (2019-nCoV) Hongzhou Lu

87 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec